TG Branfalt

Australia’s federal government is investing AU$3 million into researching the potential pain and side effect management options for cancer patients.

A recent Brightfield Group report suggests that the hemp-derived CBD market could be worth $23 billion by 2023.

After years of delays, Maine is on track to launch its adult-use cannabis industry by next March; regulations were vetoed twice by former Gov. Paul LePage (R) until lawmakers overrode his second veto last year.

A class-action lawsuit against Sundial Growers Inc. in Canada claims the company’s U.S. stock prices were affected by an unreported incident where $1.9 million worth of cannabis was returned to the company due to poor quality.

California cannabis and hemp operator Kushy Punch was raided by state officials last week, who said the company was distributing cannabis on the unregulated marketplace. Kushy Punch’s CEO said the allegations are “completely false.”

Virginia Attorney General Mark Herring said in a tweet last week that it is time for Virginia to “move toward legal, regulated adult use” cannabis. 61 percent of Virginians support legalization.

The USDA is awarding funds to research the transportation of hemp pollen in the wild; the study will use mathematical models and drone technology to monitor hemp’s pollen paths.

Jason Ambrosino is founder of the Veterans Hemp Market, a New York-based organization dedicated to providing hemp flower products for “military veterans, patriots, and the everyday warrior.”

The first cannabis tasting lounge in Nevada, where patrons will be able to smoke, vape, and consume edibles, is set to open on sovereign Paiute Tribal Land.

A study found that three out of four Canadians believe adult-use cannabis legalization has not had an impact on workplace health and safety incidents.

The Douglas County Sheriff’s Office in Nebraska says it has developed a test capable of differentiating hemp from cannabis plants; the field test was validated by the sheriff’s laboratory.

The National Industrial Hemp Council and the American Farm Bureau Federation are teaming up to lobby the EPA into approving 10 submitted pesticide applications for hemp production.

A new law in Delaware will let physicians certify patients for medical cannabis even if they don’t have one of the state program’s qualifying conditions — patients thusly approved, however, must have a severe and debilitating condition and all standard care practices must be exhausted.

A new experimental cannabis marketplace in The Netherlands will require all distributed cannabis products to utilize plain white, “unattractive” packaging that includes health warnings and only black Helvetica font.

A proposal in San Diego, California would ban cannabis billboards within 1,000 feet of schools, playgrounds, public parks, daycare centers, and youth centers.

Canada’s cannabis industry contributed $8.26 billion to the country’s national gross domestic product as of July; that rise corresponds with a decline in other traditional industries, like mining, construction, and manufacturing.

A $1 million private donation to the Oregon State University’s Global Hemp Innovation Center will fund research into hemp’s industrial applications and use in consumer goods and health products.

The first adult-use cultivation licenses have been awarded in Illinois; shops are expected to open their doors to adult-use customers on January 1, 2020.

A Kentucky hemp farm is suing an Oregon hemp seed supplier over $44 million in lost profits after the Oregon firm allegedly failed to provide feminized seeds during a cross-country, 6-million hemp seed deal.

Connecticut health officials have recommended adding chronic pain and Ehlers-Danlos syndrome as qualifying conditions for the state’s medical cannabis program.

77 percent of patients affected by the vape-linked pulmonary illness were using vaporizers containing both THC and nicotine; “nearly all” of the cannabis vape products, however, were obtained from “friends, family members, illicit dealers, or off the street.”

Kentucky hemp applications are set to open in about a month; interested farmers will have until March 15, 2020, to submit applications.

GW Pharmaceuticals is partnering up with New York’s Montefiore Medical Center to study CBDV, or cannabidivarin, as a treatment for autism.

A hemp farm in Whitefield, Maine has opened its doors as a pick-your-own establishment; it’s the first farm in Maine to do so and is believed to be the second publicly accessible hemp farm in the nation.